Review
Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

https://doi.org/10.1016/0022-510X(82)90026-0Get rights and content

Abstract

Cortical biopsies were taken from the frontal lobe of 25 patients with presenile dementia. Choline acetyltransferase (ChAT) activity, and in some specimens the high affinity uptake of choline, was used to estimate loss of cholinergic nerve terminals. Of the 15 samples with varying degrees of histological evidence of Alzheimer's disease (AD) 14 were from clinically suspected examples of the disease. There was significant loss of ChAT in 10 of the 15 compared with control and the mean activity was also highly significantly reduced (to 41% of control). The deficit was found in patients examined within a year of onset of symptoms. In 6 biopsies from clinically suspected cases of AD without diagnostic histological features there was loss of activity in only one, subsequently shown to have Jakob-Creutzfeldt disease. The remaining samples were two of vascular dementia (no loss of ChAT), one probable disorder of white matter (no loss of activity) and one undiagnosed disorder (with loss of ChAT activity). Thus most patients without histologically demonstrated AD had no evidence of a presynaptic cholinergic defect. It was concluded that suspected cases of AD particularly suitable for putative cholinergic therapy were those with an onset of the disease at 55 to 65 and an absence of family history.

References (30)

  • J.L. Cummings et al.

    Klüver-Bucy syndrome in Pick disease — Clinical and pathological correlations

    Neurology (Minneap.)

    (1982)
  • P. Davies et al.

    Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brain

    Brain Res.

    (1978)
  • F. Fonnum

    A rapid radiochemical method for the determination of choline acetyltransferase activity

    J. Neurochem.

    (1975)
  • E. Friedman et al.

    Clinical response to choline plus piracetam in senile dementia — Relation to red cell choline levels

    N. Engl. J. Med.

    (1981)
  • E.A. Haan et al.

    Protection of neocortical tissue prisms from freeze-thaw injury by dimethyl sulphoxide

    J. Neurochem.

    (1981)
  • Cited by (188)

    • Aronia melanocarpa (Michx.) Elliot fruit juice reveals neuroprotective effect and improves cognitive and locomotor functions of aged rats

      2019, Food and Chemical Toxicology
      Citation Excerpt :

      Neurotransmission in the cholinergic system is involved in processes, such as learning, memory, sleep, etc. Moreover, cholinergic innervation is directly related to memory consolidation processes (Bowen et al., 1982; Squire et al., 1992) and problems with neurotransmission elicit changes in these functions, which may be one of the causes of senile dementia or Alzheimer disease (Davies, 1983; Orta-Salazar et al., 2014). The selective lesion of cholinergic neurons in the basal forebrain significantly impairs hippocampus-dependent memory function, suggesting a role of septohippocampal cholinergic projections in memory formation (Berger-Sweeney et al., 2001).

    • Chronic treatment with taurine after intracerebroventricular streptozotocin injection improves cognitive dysfunction in rats by modulating oxidative stress, cholinergic functions and neuroinflammation

      2017, Neurochemistry International
      Citation Excerpt :

      Apart from cholinesterases, choline acetyltransferase (ChAT) being a rate limiting enzyme in synthesis plays a prominent role in maintenance of ACh level. Bowen et al. (1982) had reported decreased ChAT activity in demented patients. Results of this study revealed that the expression of ChAT was significantly decreased in hippocampus, while insignificant decrease was observed in the cortex of ICV-STZ group.

    • Nonvascular retinal imaging markers of preclinical Alzheimer's disease

      2016, Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
      Citation Excerpt :

      Although we acknowledge that symptomatic AD patients have shown a thinning of the RNFL [19,41], in contrast to our current findings in the preclinical population, we hypothesize that the finding that the cholinergic-rich IPL seems to be the central neuronal layer affected in our population is important and specific to a preclinical AD population. A disruption to the cortical cholinergic system is one of the most reliable and earliest neurochemical changes in AD [50]. Recent imaging studies of the cortical cholinergic system in living AD patients have supported an early cholinergic disruption [51,52].

    • Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease

      2013, Neurobiology of Aging
      Citation Excerpt :

      Considering the marked BF atrophy rates in healthy elderly observed in the present study, age-related atrophy should be less developed in younger control groups and thus, structural differences attributable to early AD pathology should be more pronounced and easier to detect. Accordingly, postmortem studies found that cholinergic loss in initial stages of the disease is easier to detect in presenile than in senile AD (Bowen et al., 1982; DeKosky et al., 2002; Gilmor et al., 1999) and, likewise, it has been hypothesized that this observation might be explained by age-related cholinergic decline (Mesulam, 2004). Baseline differences in BF and hippocampus volume between healthy control subjects and vmAD resemble the findings of our previous cross-sectional in vivo study on BF degeneration in aging and early AD (Grothe et al., 2012).

    View all citing articles on Scopus

    This work was financially supported by the Brain Research Trust, Medical Research Council and Miriam Marks Charitable Trust.

    Present address: The Queen Elizabeth Hospital for Children London, Great Britain.

    ∗∗

    Present address: Wessex Neurological Centre, Southampton General Hospital, Great Britain.

    View full text